"Existing antibiotics are becoming less effective as bacteria evolve, but the market that should be developing new antibacterial medicines is failing..There are only 8 antibiotics in the late stages of development and only 3 are considered innovative"
marketplace.org
marketplace.org
"Large pharma companies, which traditionally have developed these antibiotics, have largely exited both the research space and the commercialization space..Investors have walked away from this sector..
Theyโve walked away because the current economics often donโt work."
Theyโve walked away because the current economics often donโt work."
"Whatโs different about antibiotics is that when you develop a really good one, it shouldnโt be used very much..Antibiotics, especially new ones, should not be put in every medicine cabinet, but rather used only when absolutely necessary."
"Sales are low and..not enough to sustain ongoing operations.., let alone to give a return on investment..In many cases, it costs hundreds of millions of dollars more to develop an antibiotic than will be earned from it"
Loading suggestions...